Eplerenone – December 2025

• Brand names:
  • Inspra®
• Pharmaceutical Company:
  • VIATRIS PTY LTD
• Condition/Indication: Heart failure
• Meeting Date: December 2025
• Public Summary Document (PSD) July 2025 - December 2025 PBAC Meetings – (PDF 773KB)
• Public Summary Document (PSD) July 2025 - December 2025 PBAC Meetings – (Word 155KB)

Related Public Summary Documents

• Eplerenone – July 2025